Product Information
VENLAFAXINE HCL ER 150 MG CAP is a generic product labeled by Advagen Pharma Ltd., priced at $0.1169 per EA under NDC 72888018190. Its NADAC has been published 90 times since Oct 9, 2024.
Strength
150 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888018190
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203332On Market Since
3/20/2020
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 150 MG CAP has been published 90 times since Oct 9, 2024, and over the history we have for it it has declined 17.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1169 per EA |
|---|---|
| All-time high | $0.1413 (Oct 16, 2024) |
| All-time low | $0.1057 (Nov 20, 2024) |
| 52-week high | $0.1341 |
| 52-week low | $0.1169 |
| Median price | $0.1294 |
| Average price | $0.1270 |
| Largest weekly change | -21.1% (Nov 20, 2024) |
| Weeks tracked | 90 |
| Tracking since | Oct 9, 2024 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 150 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 150 MG CAP, manufactured by Advagen Pharma Ltd., is $0.1169 per EA (NDC 72888018190), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL ER 150 MG CAP changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 150 MG CAP has declined 17.2%. It has been tracked across 90 weekly CMS publications since Oct 9, 2024.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 150 MG CAP?
Since Oct 9, 2024, the NADAC for VENLAFAXINE HCL ER 150 MG CAP has ranged from a low of $0.1057 (Nov 20, 2024) to a high of $0.1413 (Oct 16, 2024), with a median of $0.1294 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 150 MG CAP?
5 NADAC-published products share the same active ingredient, strength, and dosage form as VENLAFAXINE HCL ER 150 MG CAP, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 150 MG CAP?
VENLAFAXINE HCL ER 150 MG CAP (NDC 72888018190) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification